Clinical Scorecard: Association of R2* with Fat Fraction and Bone Mineral Density: Implications for Quantitative Osteoporosis Assessment
At a Glance
Category
Detail
Condition
Osteoporosis (OP)
Key Mechanisms
Bone mineral density (BMD) reduction influenced by bone marrow adipose tissue (BMAT) content; MRI-based quantification of fat fraction (FF) and R2* relaxation rate as biomarkers
Target Population
Patients aged ≥50 years with chronic low back pain undergoing lumbar spine imaging
Care Setting
Radiology and orthopedic clinical settings with access to MRI and quantitative computed tomography (QCT)
Key Highlights
BMAT plays a significant role in osteoporosis development and may affect BMD measurement accuracy.
IDEAL-IQ MRI sequences enable simultaneous acquisition of fat fraction and R2* images for vertebral bone marrow assessment.
R2* correlates with vertebral bone marrow composition and trabecular bone characteristics, potentially aiding osteoporosis evaluation.
Guideline-Based Recommendations
Diagnosis
Use QCT-based BMD measurement as the gold standard for osteoporosis diagnosis.
Incorporate MRI IDEAL-IQ sequences to quantify vertebral fat fraction and R2* values to complement BMD assessment.
Management
Consider BMAT quantification to improve accuracy of osteoporosis evaluation and monitor disease progression.
Monitoring & Follow-up
Perform serial MRI IDEAL-IQ scans to measure FF and R2* for tracking changes in bone marrow composition and bone quality.
Risks
Exclude patients with vertebral trauma, tumors, scoliosis, localized osteosclerosis, or metabolic/hematopoietic diseases other than osteoporosis to avoid confounding imaging results.
Patient & Prescribing Data
Elderly patients (≥50 years) with chronic low back pain undergoing lumbar spine imaging
Quantitative MRI parameters (FF and R2*) may provide additional biomarkers for osteoporosis assessment beyond traditional BMD, potentially guiding personalized management.
Clinical Best Practices
Use standardized MRI protocols (3.0-T scanner, IDEAL-IQ sequence) for consistent acquisition of FF and R2* images.
Measure FF and R2* in the first to fifth lumbar vertebrae using defined regions of interest avoiding vertebral vein sulcus.
Ensure interobserver reliability by having experienced radiologists independently measure and average FF and R2* values.
Calibrate QCT equipment with quality control phantoms and use standardized ROI placement for BMD measurement.
Classify vertebrae into normal, osteopenia, and osteoporosis groups based on QCT BMD thresholds (>120, 80–120, ≤80 mg/cm³ respectively).
Apply appropriate statistical analyses including intraclass correlation coefficient for measurement consistency and ROC curve analysis for diagnostic efficacy.
Most surgeons reported using intraoperative parathyroid hormone monitoring, but approaches to imaging and intraoperative criteria varied, particularly in secondary and tertiary disease
"This could assist healthcare professionals in making more informed decisions, ultimately reducing the incidence and impact of osteoporotic fractures.”
